This website is intended for use by healthcare professionals (HCPs). The information provided is for educational purposes and does not constitute medical advice to diagnose or treat a health problem or disease. HCPs should use their independent medical judgement for clinical decision-making based on the medical condition(s) of individual patients.

Disclaimer Close Btn

Supporting Healthcare
Professional Knowledge about
CYSTIC FIBROSIS

BMI, body mass index; CFTR, cystic fibrosis transmembrane conductance regulator.

References: 1. Muhlebach MS, Clancy JP, Heltshe SL, et al. Biomarkers for cystic fibrosis drug development. J Cyst Fibros. 2016;15:714-723. 2. McKone EF, Velentgas P, Swenson AJ, Goss CH. Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype. J Cyst Fibros. 2015;14:580-586. doi:10.1016/j.jcf.2015.01.005 3. Supplement to: McKone EF, Velentgas P, Swenson AJ, Goss CH. Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype. J Cyst Fibros. 2015;14:580-586. doi:10.1016/j.jcf.2015.01.005 4. Elborn JS. Cystic fibrosis. Lancet. 2016;388(10059):2519-2531. doi:10.1016/S0140-6736(16)00576-6